128 related articles for article (PubMed ID: 12505145)
1. Augmentation of clozapine partial responders with conventional antipsychotics.
Rajarethinam R; Gilani S; Tancer M; DeQuardo J
Schizophr Res; 2003 Mar; 60(1):97-8. PubMed ID: 12505145
[No Abstract] [Full Text] [Related]
2. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine.
Zahn TP; Pickar D
Biol Psychiatry; 1993 Jul 1-15; 34(1-2):3-12. PubMed ID: 8104043
[TBL] [Abstract][Full Text] [Related]
3. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
Rapaport MH; McAllister CG; Kirch DG; Pickar D
Biol Psychiatry; 1991 Apr; 29(7):715-7. PubMed ID: 1711382
[No Abstract] [Full Text] [Related]
4. Clozapine as a first treatment for schizophrenia.
Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
6. Clozapine compared with haloperidol for refractory schizophrenia.
Birkett DP
N Engl J Med; 1998 Jan; 338(4):267-8. PubMed ID: 9441246
[No Abstract] [Full Text] [Related]
7. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action.
Breier A; Elman I; Goldstein DS
Adv Pharmacol; 1998; 42():785-8. PubMed ID: 9328015
[No Abstract] [Full Text] [Related]
8. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
[TBL] [Abstract][Full Text] [Related]
9. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Melkersson K; Lewitt M; Hall K
Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride augmentation of clozapine in refractory schizophrenia.
Chiu HW; Ku YC; Li TC; Huang HT
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
[No Abstract] [Full Text] [Related]
11. The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.
Zuo L; Luo X; Krystal JH; Cramer J; Charney DS; Gelernter J
Pharmacogenet Genomics; 2009 Jun; 19(6):437-46. PubMed ID: 19369910
[TBL] [Abstract][Full Text] [Related]
12. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
14. Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Uchida T; Suzuki T; Sakurai H; Tsutsumi C; Den R; Mimura M; Uchida H
Int Clin Psychopharmacol; 2013 Sep; 28(5):261-6. PubMed ID: 23820334
[TBL] [Abstract][Full Text] [Related]
15. Sexual side effects of novel antipsychotic medications.
Wirshing DA; Pierre JM; Marder SR; Saunders CS; Wirshing WC
Schizophr Res; 2002 Jul; 56(1-2):25-30. PubMed ID: 12084416
[TBL] [Abstract][Full Text] [Related]
16. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
Gazdag G; Tolna J; Bitter I
Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
[TBL] [Abstract][Full Text] [Related]
17. Similarities and differences among antipsychotics.
Tamminga CA
J Clin Psychiatry; 2003; 64 Suppl 17():7-10. PubMed ID: 14680420
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
[No Abstract] [Full Text] [Related]
19. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
20. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J
Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]